These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 2544862)

  • 1. Nucleotide sequence of the recA gene of Proteus mirabilis.
    Akaboshi E; Yip ML; Howard-Flanders P
    Nucleic Acids Res; 1989 Jun; 17(11):4390. PubMed ID: 2544862
    [No Abstract]   [Full Text] [Related]  

  • 2. Sequence of the Proteus mirabilis urease accessory gene ureG.
    Sriwanthana B; Island MD; Mobley HL
    Gene; 1993 Jul; 129(1):103-6. PubMed ID: 8335248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new tetracycline resistance determinant cloned from Proteus mirabilis.
    Magalhães VD; Schuman W; Castilho BA
    Biochim Biophys Acta; 1998 Nov; 1443(1-2):262-6. PubMed ID: 9838156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteus mirabilis MR/P fimbrial operon: genetic organization, nucleotide sequence, and conditions for expression.
    Bahrani FK; Mobley HL
    J Bacteriol; 1994 Jun; 176(11):3412-9. PubMed ID: 7910820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cloning of Proteus mirabilis uroepithelial cell adherence (uca) genes.
    Cook SW; Mody N; Valle J; Hull R
    Infect Immun; 1995 May; 63(5):2082-6. PubMed ID: 7729924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbenicillin-hydrolysing penicillinase mediated by a plasmid of Proteus mirabilis and its relationship to the PSE-type enzymes of Pseudomonas aeruginosa.
    Ito Y; Hirano T
    J Appl Microbiol; 1997 Aug; 83(2):175-80. PubMed ID: 9281821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The XerC recombinase of Proteus mirabilis: characterization and interaction with other tyrosine recombinases.
    Villion M; Szatmari G
    FEMS Microbiol Lett; 2003 Sep; 226(1):65-71. PubMed ID: 13129609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of an
    Wang X; Zhai W; Li J; Liu D; Zhang Q; Shen Z; Wang S; Wang Y
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203482
    [No Abstract]   [Full Text] [Related]  

  • 9. Nucleotide sequence analysis of the cat gene of Proteus mirabilis: comparison with the type I (Tn9) cat gene.
    Charles IG; Keyte JW; Shaw WV
    J Bacteriol; 1985 Oct; 164(1):123-9. PubMed ID: 3900035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the carboxypeptidase T gene from Thermoactinomyces vulgaris in stable protoplast type L-forms of Proteus mirabilis.
    Bushueva AM; Shevelev AB; Gumpert J; Chestukhina GG; Serkina AV; Hoischen C; Matz MV; Kuryatova MV; Stepanov VM
    FEMS Microbiol Lett; 1998 Feb; 159(2):145-50. PubMed ID: 9503606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic determinants of self identity and social recognition in bacteria.
    Gibbs KA; Urbanowski ML; Greenberg EP
    Science; 2008 Jul; 321(5886):256-9. PubMed ID: 18621670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel type 1/2 hybrid IncC plasmid carrying fifteen antimicrobial resistance genes recovered from Proteus mirabilis in China.
    Lei CW; Kong LH; Ma SZ; Liu BH; Chen YP; Zhang AY; Wang HN
    Plasmid; 2017 Sep; 93():1-5. PubMed ID: 28757095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Four variants of the Citrobacter freundii AmpC-Type cephalosporinases, including novel enzymes CMY-14 and CMY-15, in a Proteus mirabilis clone widespread in Poland.
    Literacka E; Empel J; Baraniak A; Sadowy E; Hryniewicz W; Gniadkowski M
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4136-43. PubMed ID: 15504832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression, purification, and characterization of a membrane-bound D-amino acid dehydrogenase from Proteus mirabilis JN458.
    Xu J; Bai Y; Fan T; Zheng X; Cai Y
    Biotechnol Lett; 2017 Oct; 39(10):1559-1566. PubMed ID: 28676939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of CMY-4, an AmpC-type plasmid-mediated beta-lactamase in a Tunisian clinical isolate of Proteus mirabilis.
    Verdet C; Arlet G; Ben Redjeb S; Ben Hassen A; Lagrange PH; Philippon A
    FEMS Microbiol Lett; 1998 Dec; 169(2):235-40. PubMed ID: 9868767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleotide sequence of the bla(RTG-2) (CARB-5) gene and phylogeny of a new group of carbenicillinases.
    Choury D; Szajnert MF; Joly-Guillou ML; Azibi K; Delpech M; Paul G
    Antimicrob Agents Chemother; 2000 Apr; 44(4):1070-4. PubMed ID: 10722515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal Amplification of the blaOXA-58 Carbapenemase Gene in a Proteus mirabilis Clinical Isolate.
    Girlich D; Bonnin RA; Bogaerts P; De Laveleye M; Huang DT; Dortet L; Glaser P; Glupczynski Y; Naas T
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allelic Exchange Mutagenesis in Proteus mirabilis.
    Howery KE; Rather PN
    Methods Mol Biol; 2019; 2021():77-84. PubMed ID: 31309497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The new variant of Salmonella genomic island 1 (SGI1-V) from a Proteus mirabilis French clinical isolate harbours blaVEB-6 and qnrA1 in the multiple antibiotic resistance region.
    Siebor E; Neuwirth C
    J Antimicrob Chemother; 2011 Nov; 66(11):2513-20. PubMed ID: 21846670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteus mirabilis clinical isolate harbouring a new variant of Salmonella genomic island 1 containing the multiple antibiotic resistance region.
    Ahmed AM; Hussein AI; Shimamoto T
    J Antimicrob Chemother; 2007 Feb; 59(2):184-90. PubMed ID: 17114173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.